Aziyo Biologics

Human tissue allografts

Stryker partners with Aziyo to provide a wide variety of human tissue allografts.


  • Terminal sterilization performed at ultra-low temperatures and at low doses not exceeding 25 kGy, which better preserves the tissue structure2

  • SAL of 10-6 translates to a 1,000-fold lower probability of contamination compared to an SAL of 10-3

  • Sterilization process validated by Method VDmax15 to ANSI/AAMI/ISO 11137, including periodic dose auditing

  • Inactivates a broad range of viruses, reducing the potential for infection1

Resources and downloads